Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person5
FibroBiologics, Inc.
Company
HCW Biologics Inc.
Company
ADMA BIOLOGICS, INC.
Company
Theriva Biologics, Inc.
Company
AbCellera Biologics Inc.
Company
Primary record8
CytoDyn Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 16, 2026, at a meeting held by the Board of Director
FibroBiologics, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On October 7, 2026, FibroBiologics, Inc. (the Company ) entered into a securities purchase agreement (the SPA ) with Peak One Opportunity Fund, L.P. ( Peak One ), pur
FibroBiologics, Inc. filed 8-K
Item 5.07 Submission of Matters to a Vote of Security Holders. FibroBiologics, Inc. (the Company ) held a Special Meeting of Stockholders on September 17, 2026 (the Special Meeting ). Proxies for the Special Meeting were
FibroBiologics, Inc. filed SCHEDULE 13D
on Form 8-K (File No. 001-41934) filed on September 15, 2026). Exhibit 10.1 Securities Purchase Agreement dated September 15, 2026, between FibroBiologics, Inc. and Hamid Khoja, Ph.D. (incorporated by reference to Exhibi
FibroBiologics, Inc. filed 4
SEC form 4 filed by FibroBiologics, Inc. (CIK 1958777) on 2026-09-15.
FibroBiologics, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On September 15, 2026, FibroBiologics, Inc. (the Company ) entered into a securities purchase agreement (the SPA ) with Hamid Khoja, Ph.D., the Company s Chief Scient
FibroBiologics, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 20, 2026, the Board of Directors (the Board ) of Fibr
ARMISTICE CAPITAL, LLC filed SCHEDULE 13G
0001172661-26-003577.txt : 20260814 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001601086 XXXXXXXX LIVE Common Stock, $0.00001 par value 06/30/2026 0001958777 FibroBiologics, Inc. 31573L204 9350 Kirby Drive, Suite